Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Menderes

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Minimally Invasive Gynecology|September 29, 2016
Comparison of Robotics Versus Conventional Laparoscopy for Management of Benign Adnexal MassesT Zigras, L Goodman, G Menderes, et al.
Journal of Minimally Invasive Gynecology|September 29, 2016
Laparoscopic Ovarian TranspositionF Kakar, D English, G Menderes, et al.
Journal of Minimally Invasive Gynecology|September 29, 2016
Early Stage Uterine Serous Carcinoma: Does Surgical Approach Impact Survival?M Clark, M Glasgow, G Menderes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2021
A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)S Bellone, D M Roque, E R Siegel, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Minimally Invasive Gynecology|September 29, 2016
Comparison of Robotics Versus Conventional Laparoscopy for Management of Benign Adnexal MassesT Zigras, L Goodman, G Menderes, et al.
Journal of Minimally Invasive Gynecology|September 29, 2016
Laparoscopic Ovarian TranspositionF Kakar, D English, G Menderes, et al.
Journal of Minimally Invasive Gynecology|September 29, 2016
Early Stage Uterine Serous Carcinoma: Does Surgical Approach Impact Survival?M Clark, M Glasgow, G Menderes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2021
A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)S Bellone, D M Roque, E R Siegel, et al.
Pageof 1